尼日尔农村孕期多种微量营养素补充与中等剂量脂基营养素补充对儿童发育影响的评估:一项整群随机对照试验的二次分析
该整群随机对照试验在尼日尔农村比较孕期多种微量营养素补充(MMS)、脂基营养素补充(LNS)与常规铁叶酸(IFA)补充对儿童发育的影响。结果显示,与IFA相比,MMS对2岁内儿童BSID-III认知、语言、运动评分及WHO粗大运动里程碑达成时间均无影响;LNS对24月龄终点BSID-III评分无影响,但LNS组儿童18和21月龄认知评分较高(约0.35 SD),独坐和独走达成时间更早。
要点
- 与IFA相比,孕期MMS对2岁内儿童BSID-III认知、语言、运动评分及WHO粗大运动里程碑达成时间均无影响。
- 与IFA相比,孕期LNS对24月龄终点BSID-III认知、语言、运动评分无影响。
- LNS组儿童18和21月龄认知评分较IFA组高约0.35 SD,独坐(HR 1.57)和独走(HR 1.52)达成更早。
核心结论
- 与IFA相比,孕期MMS对2岁内儿童发育结局无益处。
- 有证据表明孕期LNS对认知发育轨迹和部分粗大运动里程碑达成时间具有表观正向效应。
研究设计与样本
- 研究为3臂整群随机对照试验(n=53个整群),在尼日尔Madarounfa农村地区于2015年3月至2019年8月开展(ClinicalTrials.gov标识NCT02145000)。
- 孕期MMS组18个整群,LNS组18个整群,常规IFA组17个整群。
- 儿童随访至2岁,从6至24月龄每3个月施测Bayley婴幼儿发育量表第三版(BSID-III),从3至24月龄每月评估母亲报告的WHO粗大运动里程碑达成情况,采用意向性治疗分析。
- BSID-III数据分别有MMS组559名、LNS组492名、IFA组581名独生子女儿童;WHO运动里程碑数据分别有MMS组691名、LNS组781名、IFA组753名独生子女儿童。
主要发现
- 与IFA相比,孕期MMS对儿童BSID-III认知评分(标准化均数差[SMD]:0.21;95%CI:-0.20,0.62;p=0.32)、语言评分(SMD:0.16;95%CI:-0.30,0.61;p=0.50)或运动评分(SMD:0.18;95%CI:-0.39,0.74;p=0.54)无影响,对WHO粗大运动里程碑达成时间也无影响。
- 与IFA相比,孕期LNS对24月龄终点访视时儿童BSID-III认知评分(SMD:0.17;95%CI:-0.15,0.49;p=0.29)、语言评分(SMD:0.11;95%CI:-0.22,0.44;p=0.53)或运动评分(SMD:-0.04;95%CI:-0.46,0.37;p=0.85)无影响。
- 生命前2年BSID-III认知评分轨迹在组间存在差异,LNS组儿童在18和21月龄时认知评分较IFA组高约0.35 SD(轨迹差异p值<0.001)。
- 母亲接受LNS的儿童独坐达成时间(风险比[HR]:1.57;95%CI:1.10至2.24;p=0.01)和独走达成时间(HR:1.52;95%CI:1.14至2.03;p=0.004)较IFA组更早,但其他运动里程碑达成时间无影响。
局限性
- 研究局限性为仅评估儿童发育至2岁,因此可能未能捕捉到在较大年龄更易检测或才出现的效应。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: It is estimated that over 250 million children under 5 years of age in low- and middle-income countries (LMICs) do not reach their full developmental potential. Poor maternal diet, anemia, and micronutrient deficiencies during pregnancy are associated with suboptimal neurodevelopmental outcomes in children. However, the effect of prenatal macronutrient and micronutrient supplementation on child development in LMIC settings remains unclear due to limited evidence from randomized trials. METHODS AND FINDINGS: We conducted a 3-arm cluster-randomized trial (n = 53 clusters) that evaluated the efficacy of (1) prenatal multiple micronutrient supplementation (MMS; n = 18 clusters) and (2) lipid-based nutrient supplementation (LNS; n = 18 clusters) as compared to (3) routine iron-folic acid (IFA) supplementation (n = 17 clusters) among pregnant women in the rural district of Madarounfa, Niger, from March 2015 to August 2019 (ClinicalTrials.gov identifier NCT02145000). Children were followed until 2 years of age, and the Bayley Scales of Infant and Toddler Development III (BSID-III) were administered to children every 3 months from 6 to 24 months of age. Maternal report of WHO gross motor milestone achievement was assessed monthly from 3 to 24 months of age. An intention-to-treat analysis was followed. Child BSID-III data were available for 559, 492, and 581 singleton children in the MMS, LNS, and IFA groups, respectively. Child WHO motor milestone data were available for 691, 781, and 753 singleton children in the MMS, LNS, and IFA groups, respectively. Prenatal MMS had no effect on child BSID-III cognitive (standardized mean difference [SMD]: 0.21; 95% CI: -0.20, 0.62; p = 0.32), language (SMD: 0.16; 95% CI: -0.30, 0.61; p = 0.50) or motor scores (SMD: 0.18; 95% CI: -0.39, 0.74; p = 0.54) or on time to achievement of the WHO gross motor milestones as compared to IFA. Prenatal LNS had no effect on child BSID-III cognitive (SMD: 0.17; 95% CI: -0.15, 0.49; p = 0.29), language (SMD: 0.11; 95% CI: -0.22, 0.44; p = 0.53) or motor scores (SMD: -0.04; 95% CI: -0.46, 0.37; p = 0.85) at the 24-month endline visit as compared to IFA. However, the trajectory of BSID-III cognitive scores during the first 2 years of life differed between the groups with children in the LNS group having higher cognitive scores at 18 and 21 months (approximately 0.35 SD) as compared to the IFA group (p-value for difference in trajectory <0.001). Children whose mothers received LNS also had earlier achievement of sitting alone (hazard ratio [HR]: 1.57; 95% CI: 1.10 to 2.24; p = 0.01) and walking alone (1.52; 95% CI: 1.14 to 2.03; p = 0.004) as compared to IFA, but there was no effect on time to achievement of other motor milestones. A limitation of our study is that we assessed child development up to 2 years of age, and, therefore, we may have not captured effects that are easier to detect or emerge at older ages. CONCLUSIONS: There was no benefit of prenatal MMS on child development outcomes up to 2 years of age as compared to IFA. There was evidence of an apparent positive effect of prenatal LNS on cognitive development trajectory and time to achievement of selected gross motor milestones. TRIAL REGISTRATION: ClinicalTrials.gov NCT02145000.
引用
- Sudfeld CR, Bliznashka L, Salifou A, et al. Evaluation of multiple micronutrient supplementation and medium-quantity lipid-based nutrient supplementation in pregnancy on child development in rural Niger: A secondary analysis of a cluster randomized controlled trial. PLoS Med. 2022. PMID: 35500028. doi:10.1371/journal.pmed.1003984
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。